A 25% U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly $51 billion annually, boosting U.S.

India's economy is projected to grow at 6.5% in FY26, buoyed by lower crude oil prices and controlled inflation, despite ...

The board of IndusInd Bank has engaged global professional services firm EY to conduct a second forensic audit. This audit ...

Andrea Guerzoni, EY Parthenon, Global Vice Chair speaks with Romaine Bostick and Scarlet Fu about CEO sentiment and the M&A ...

Ernst & Young LLP (EY US) has appointed Martin Fiore as the Americas vice-chair of tax, effective 1 July. Fiore will succeed Kevin Flynn, who has led the business since 2022 and is set to retire at ...

After an agreement allowed employees to work up to 58-hour weeks, the firm's unions asked its employees for their opinions, ...

Despite global trade tensions, India's economy is projected to grow at 6.5% in FY26, according to EY. Lower crude oil prices ...

India’s economy continues to show signs of stability and resilience despite global uncertainties, according to EY’s Economy ...

The analysis, conducted by Ernst & Young, found the United States imported $203 billion in pharmaceutical products in 2023, ...

India may be able to sustain a real GDP growth at about 6.5 per cent in FY26. The country is well-positioned to navigate ...